Director's shareholding

RNS Number : 0174M

Futura Medical PLC

17 May 2010

 



For immediate release

17 May 2010

 

Futura Medical plc

("Futura" or "the Company")

Director's shareholding

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has received notification from James Barder, the Chief Executive of the Company, that the 100,000 Futura ordinary shares held jointly by his children will no longer be treated as consolidated within his and his wife's holding for the purposes of the AIM Rules as his children are no longer under 18 years of age.  As such his aggregate beneficial and non-beneficial holdings will be 745,212 ordinary shares, representing 1.1 per cent of Futura's ordinary share capital.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Stasa Filiplic / George Prassas	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSUBVBRRKAVARR